جست‌وجوی استاد و پژوهشگر

Samantha J. Harrisمشاهده پروفایل

عضو هیئت علمی

• Health Policy
• Health Services Research
• Substance Use Treatment
• +۸ مورد دیگر

Samantha J. Harris, PhD, MPA, is an Assistant Scientist in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her primary appointment is with the Bloomberg Overdose Prevention Initiative, where she leads state-level evaluations in Kentucky and New Mexico, focusing on overdose prevention and implementation of harm reduction policies. Institution: Johns Hopkins University School: Bloomberg School of Public Health Department: Department of Health Policy and Management Position: Assistant Scientist Education: PhD in Health Policy, University of Georgia, 2021 MPA in Health Policy, University of Kentucky, 2016 BA in Arts Administration, University of Kentucky, 2014 Postdoctoral Training, Johns Hopkins Bloomberg School of Public Health Samantha Harris's research centers on improving access to mental health and substance use treatment, particularly through public insurance programs like Medicaid and Medicare. Her work applies mixed-methods approaches to evaluate policies related to harm reduction, overdose prevention, and service delivery within the criminal legal system. She has a strong interest in aging and health, opioid and alcohol use disorders, and equitable access to care. Her recent publications highlight trends in Medicare coverage for methadone and buprenorphine, implementation of syringe services programs, and attitudes toward decriminalization policies. Her work spans qualitative and quantitative methods, often focusing on policy impact and implementation barriers at the state level. Scientific Contributions: Lead researcher on rapid-cycle evaluations of overdose prevention programs Co-Investigator on NIH, SAMHSA, and privately funded projects Frequent collaborator with interdisciplinary teams and state agencies Harris has served in policy-focused fellowship placements and contributes to high-impact journals such as Health Affairs and Drug and Alcohol Dependence . She advises on policy evaluation and health services research but no formal students are listed. She is actively involved in the Bloomberg Overdose Prevention Initiative, working closely with Dr. Brendan Saloner and Dr. Sachini Bandara. Her lab or team is embedded within this initiative, conducting real-time assessments of innovative state policies to reduce fatal overdoses.

Susan Gail Shermanمشاهده پروفایل

استاد

• Harm Reduction
• Drug Policy
• HIV Prevention
• +۱۰ مورد دیگر

Susan Gail Sherman, PhD, MPH, is a Professor in the Department of Health, Behavior and Society at Johns Hopkins Bloomberg School of Public Health. She holds joint appointments in Population, Family and Reproductive Health, Epidemiology, and Mental Health departments. Dr. Sherman is Co-Director of the Baltimore HIV Collaboratory and part of the Executive Leadership Committee of the Johns Hopkins Center for AIDS Research. She co-leads the Addiction and Overdose workgroup of the Bloomberg American Health Initiative and serves on Baltimore City and state advisory commissions on syringe exchange and overdose prevention initiatives. Dr. Sherman earned her PhD from Johns Hopkins Bloomberg School of Public Health in 2000, MPH from University of North Carolina at Chapel Hill in 1996, and BA from University of Michigan in Ann Arbor in 1989. Her research focuses on improving the health of marginalized populations, particularly drug users and sex workers, with emphasis on structural drivers of health. She has over 17 years of experience developing and evaluating HIV prevention, peer-outreach behavioral, and microenterprise interventions in Baltimore, Pakistan, Thailand, and India. Her research spans the intersection of public health and public safety, harm reduction evidence for drug policy, economic development as HIV prevention, and structural determinants of health. Dr. Sherman is PI of studies examining police roles in the STI/HIV risk environment of street-based sex workers and evaluating innovative pre-booking diversion programs for low-level drug offenders. She is also developing a full-service drop-in center for sex workers in Baltimore. Analysis of her recent publications reveals a strong focus on harm reduction, opioid crisis interventions, structural determinants of health, and the intersection of public health and law enforcement. Her work increasingly addresses gender-specific vulnerabilities, particularly among women who use drugs and sex workers, while maintaining a strong commitment to evidence-based policy solutions. 2011 Advising, Mentoring & Teaching Recognitions Award, Johns Hopkins Bloomberg School of Public Health 2006 Advising, Mentoring & Teaching Recognitions Award, Johns Hopkins Bloomberg School of Public Health 2002 Delta Omega Society 1997-2000 NIMH Predoctoral Training Grantee, Office of AIDS Dr. Sherman has received significant grant funding for her work, including the FORECAST (Fentanyl Overdose Reduction Checking Analysis Study) and the SAPPHIRE (Sex Workers and Police Promoting Health in Risky Environments) study. She serves as PI for multiple projects examining structural interventions with sex workers and drug users in Baltimore. Her research portfolio includes international work in Pakistan, Thailand, and India on HIV prevention and microenterprise interventions. Dr. Sherman is actively involved with the Center for AIDS Research, Center for Global Health, Center for Public Health and Human Rights, and Center for Sexually Transmitted Diseases Research, Prevention and Training. She serves as Board Secretary of the National Harm Reduction Coalition and is deeply engaged with community-based organizations working with marginalized populations.

• Substance Use and Addiction
• HIV/AIDS Prevention
• Viral Hepatitis Transmission
• +۵ مورد دیگر

Robert Heimer is a Professor of Epidemiology (Microbial Diseases) and Pharmacology at Yale University, with affiliations to the Yale School of Public Health , Center for Interdisciplinary Research on AIDS (CIRA) , and Yale Institute for Global Health . His research focuses on substance use epidemiology , HIV and viral hepatitis prevention , and harm reduction strategies , particularly addressing the opioid crisis through interdisciplinary methods combining laboratory, behavioral, and structural analyses. PhD in Molecular Biology/Pharmacology (Yale University, 1988) BA in Molecular Biology (Columbia College, 1974) His work examines injection drug use consequences , syringe exchange programs , overdose prevention , and pharmacological addiction treatment , with funding from NIH, CDC, and Gilead Foundation. Recent publications analyze spatial overdose patterns , opioid treatment accessibility , and structural stigma in rural healthcare . He has contributed to understanding HIV transmission in Russia and global harm reduction policy . Scientific Awards: Recognized through Annual Research Awards and Career Achievement Awards at Yale School of Public Health. Dr. Heimer directs the Interdisciplinary Research Methods Core at CIRA and conducts fieldwork in Vietnam and Lebanon, addressing cross-border substance use challenges and stigma in marginalized populations . His research informs public health policy and prison-to-community healthcare transitions .

• Implementation Science
• Mental Health
• Person-Centered Care
• +۷ مورد دیگر

Mimi Choy-Brown is an Associate Professor in the School of Social Work at the University of Minnesota, Twin Cities. Her work centers on implementation science, mental health services research, clinical supervision, and organizational strategies to reduce health disparities. She is actively involved in multiple NIH- and SAMHSA-funded research projects addressing HIV stigma, telehealth access for marginalized populations, and workforce retention in mental health care. University: University of Minnesota School: School of Social Work Department: Social Work Rank: Associate Professor Her research interests focus on improving mental health equity through systemic interventions. Key areas include implementation science , person-centered care , clinical supervision , organizational culture , and healthcare access for vulnerable populations such as refugees, immigrants, and people who inject drugs. She applies mixed methods and implementation frameworks to evaluate and enhance service delivery models. The most recent articles (2019–2025) reflect a strong trajectory in implementation science and mental health policy. Common themes include workforce retention, fidelity monitoring, trauma-informed care, and digital health tools like clinical decision support systems. Her work often involves collaborative, interdisciplinary teams and real-world settings such as primary care clinics, syringe service programs, and child welfare agencies. Scientific contributions include: Development of multilevel frameworks for implementation trials Strategies for reducing HIV stigma using standardized patients Integration of telehealth in harm reduction settings Organizational investments to promote mental health equality She has served as Principal Investigator and Co-Investigator on multiple federally funded grants, demonstrating leadership in securing external funding. These projects emphasize community engagement, resilience-building for refugee and immigrant youth, and scalable models for mental health service delivery. Although student advisees are not listed, her supervisory focus in research suggests mentorship in clinical and organizational research methods. She leads the LIFT Project for Northwest MHTTC and contributes to national initiatives aimed at improving mental health systems. Dr. Choy-Brown is actively engaged in research teams and collaborative networks focused on implementation science, mental health equity, and public health innovation. Her work spans academic, clinical, and community-based settings, emphasizing practical solutions to systemic challenges in mental health care.

Donna J. Biedermanمشاهده پروفایل

استاد بالینی

• Public Health
• Social Determinants of Health
• Homelessness
• +۳ مورد دیگر

Donna J. Biederman is a Clinical Professor in the School of Nursing at Duke University, with a joint appointment as Professor in Family Medicine and Community Health since 2024. Her career bridges clinical practice, education, and research in public health nursing. Education: DrPH (2012) from University of North Carolina Greensboro, MN and BSN from University of Washington Tacoma Credentials: RN license (#216747) in North Carolina since 2007 Research focuses on social determinants of health , health disparities , and housing policy , particularly for marginalized populations like people experiencing homelessness. Her work explores: Transitional care models for homeless individuals Tenancy support services funded through Medicaid Stigma reduction in healthcare settings Medical respite programs Substance use treatment integration Health outcomes post-eviction Recent publications (2024-2025) highlight her leadership in: Smoke-free addiction treatment protocols Student-run housing initiatives like WellNest Policy analysis of Medicaid-funded housing support Qualitative studies on effective tenancy practices Major grants include: Nurse LEADS (2024-2029) - National Institute of Nursing Research NEPQR-MHTP (2022-2026) - Health Resources and Services Administration Back@Home Evaluation (2021-2023) - North Carolina Department of Health and Human Services Awards & Recognition: Multiple Outstanding Clinical Instructor Awards (Duke School of Nursing: 2013, 2014) "Extraordinary Nurse" nominee (NC Nurses Association, 2016) Nursing Distinguished Alumni Award (University of Washington Tacoma, 2015) She teaches courses addressing social drivers of health in rural and underserved communities (NURSING 540-543B) and oversees DNP projects since 2022.

Annette B. Gadegbekuمشاهده پروفایل

دانشیار

• Community Health
• Health Equity
• Urban and Underserved Medicine
• +۵ مورد دیگر

Annette B. Gadegbeku, MD, is an Associate Professor and Chief of the Division of Community Health in the Department of Family, Community & Preventive Medicine at Drexel University. She also serves as Senior Associate Dean in the Office of Community Health and Inclusive Excellence, overseeing initiatives to address health disparities and promote equity. Dr. Gadegbeku’s academic roles include leadership in the Healing Hurt People program at the Dornsife School of Public Health and assistant director of Diversity, Equity & Inclusion at the Sidney Kimmel Cancer Center. She holds a BA in Biology from Brown University and an MD from Temple University School of Medicine. Her clinical expertise spans primary care, preventive medicine, refugee health, and trauma-informed care. She has led community outreach programs like Drexel’s mobile COVID-19 services and advises student-run clinics such as the Health Outreach Project (HOP), which serves underserved populations in Philadelphia. Her research focuses on health equity, community engagement, and the impact of marginalized populations’ healthcare access. She emphasizes culturally responsive communication and interprofessional collaboration in medical education. Dr. Gadegbeku has received the 2024 Dr. Donna M. Murasko Award for her civic engagement efforts. She is a member of the National Academies of Practice and advises national initiatives like the Two in One HIV/COVID screening model. Her clinical services include primary care for all ages, women’s health, and refugee health. She also participates in global health missions in Jamaica, Kenya, and Puerto Rico through Glory Unlimited Ministries.

Abenaa Jonesمشاهده پروفایل

استادیار

• Substance Use Disorders
• Criminal Justice
• Women's Health
• +۸ مورد دیگر

Dr. Abenaa Jones is an Assistant Professor in the Department of Human Development and Family Studies at Pennsylvania State University, where she holds the Ann Atherton Hertzler Early Career Professorship. As director of the Addiction, Sex, and Infectious Diseases (ASID) Lab, her research focuses on the syndemic of substance use disorders, violence, sexual risk behaviors, and HIV/STIs, particularly among marginalized and criminal justice-involved women. B.S., 2012, Public and Community Health, University of Maryland Ph.D., 2016, Epidemiology, University of Florida Her work examines racial disparities in opioid overdose training, naloxone administration, and treatment access, with a focus on gender-specific interventions for criminal justice-involved women. She evaluates structural and behavioral strategies to reduce substance use harms, including medication-assisted treatment (MAT) and trauma-informed care integration. Dr. Jones’ research emphasizes multidisciplinary approaches to addiction, intersecting with social determinants like housing instability and incarceration stigma. She has secured significant funding, including an NIDA K01 Career Development Award and NIH T32 training grant, to develop interventions that address systemic barriers to recovery. Scientific awards include: Ronald E. McNair Scholar’s Program (2009) McKnight Doctoral Fellowship (2012) NIDA Diversity Scholar (2019) Bloomberg American Health Initiative Travel Award (2019) She mentors PhD students in Human Development and Family Studies and collaborates across institutions, including the Consortium to Combat Substance Abuse and the Edna Bennett Pierce Prevention Research Center. Her lab integrates expertise from epidemiology, demography, and clinical practice to address addiction and infectious disease intersections.

• HIV prevention
• substance use
• infectious diseases
• +۴ مورد دیگر

Angela Bazzi is a Professor at the Herbert Wertheim School of Public Health & Human Longevity Science at UC San Diego. Her research focuses on HIV prevention, substance use, and implementation science, with an emphasis on marginalized populations such as people who use drugs and justice-involved individuals. She holds multiple NIH grants, including roles as Principal Investigator (PI), Co-Investigator, and MPI in studies addressing PrEP implementation, overdose prevention, and healthcare access disparities. Dr. Bazzi’s education includes a PhD in Global Health from UC San Diego, an MPH in Public Health from Johns Hopkins, and a BA in International Relations from USC. Her work spans qualitative and quantitative methods, with a focus on translating research into actionable public health policies and programs. Key areas of expertise include syringe services programs, telemedicine adaptations during pandemics, and structural barriers to healthcare. She has published extensively on overdose prevention strategies, stigma reduction, and the intersection of substance use and HIV risk. Her grants include studies on peer-led interventions for drug checking services, HIV self-testing, and optimizing PrEP delivery in syringe programs. She collaborates with institutions like the Altman Clinical and Translational Research Institute and the CDC’s HEALing Communities Study.

Jennifer D. Olivaمشاهده پروفایل

استاد

• Health Law and Policy
• Privacy Law
• Evidence
• +۵ مورد دیگر

Jennifer D. Oliva is Professor of Law and Val Nolan Faculty Fellow at Indiana University Maurer School of Law, where she teaches and conducts research at the intersection of law, health policy, and technology. She also serves as a Research Scholar at Georgetown Law's O'Neill Institute for National & Global Health Law and a Senior Scholar with the UCSF/UC Law Consortium on Law, Science & Health Policy. Education: BS, United States Military Academy (West Point) MBA, University of Oxford JD, Georgetown University Law Center Professor Oliva's research focuses on critical issues in health law and policy, particularly where law intersects with public health crises, technology, and civil rights. Her work examines how legal frameworks shape healthcare access, privacy rights, and equity in medical treatment, with special attention to vulnerable populations including pregnant women, people with disabilities, and those affected by the opioid crisis. She has pioneered scholarship on prescription drug monitoring programs, algorithmic bias in healthcare, and the criminalization of drug use and pregnancy. Her extensive publication record demonstrates consistent engagement with emerging legal challenges in health policy, particularly the tension between public health approaches and punitive drug policies. Oliva's work shows a clear trajectory toward examining how technology and data systems impact healthcare equity, with recent articles addressing algorithmic bias, surveillance, and the intersection of civil rights law with healthcare delivery systems. Selected Awards: 2024 Indiana University Maurer School of Law Trustees Teaching Award 2024 Indiana University Maurer School of Law BLSA Outstanding Interactive Professor Award 2021 Health Law Community Service Award from the AALS Section on Law, Medicine, and Health Care 2019 Truman Scholarship Foundation Ike Skelton Award for commitment to public service 2021 Professor of the Year at Seton Hall University School of Law Professor Oliva has been actively involved in shaping health policy through her service as Chair of the AALS Section on Law, Medicine, and Health Care (2023) and currently as Chair-Elect of the AALS Section on Biolaw. She serves on the Johns Hopkins University/UCSF Opioid Industry Documents Archive National Advisory Committee and the National Pain Advocacy Center's Science & Policy Advisory Council, where she provides expert guidance on opioid litigation and pain management policy. Her scholarship has been instrumental in advocating for evidence-based approaches to drug policy and healthcare regulation. As an elected member of the American Law Institute, Professor Oliva contributes to the development of legal principles that shape American jurisprudence. Her military service background informs her unique perspective on veterans' issues and public service, having been selected for both Rhodes and Truman Scholarships during her time as a cadet at West Point.

Sean Travis Allenمشاهده پروفایل

دانشیار

• Public Health
• Epidemiology
• Substance Use
• +۱۲ مورد دیگر

Sean Travis Allen, DrPH, MPH, is an Associate Professor in the Department of Health, Behavior and Society at the Bloomberg School of Public Health, Johns Hopkins University. His research focuses on structural drivers of public health among marginalized populations, particularly people who use drugs. He is actively engaged in advancing harm reduction, rural health equity, and drug policy reform. Education: DrPH from The George Washington University (2015), MPH and BS from University of Kentucky (2012, 2010) Postdoctoral Training: Johns Hopkins University, Drug Dependence Epidemiology Training Program Professional Experience: Former Senior Policy Advisor, White House Office of National Drug Control Policy Dr. Allen’s research interests span rural health, HIV prevention, harm reduction, drug policy, injection drug use, overdose prevention, geospatial analyses, and epidemiology. His work emphasizes structural interventions and policy change as tools for reducing health disparities. The recent publications reflect a strong trend in harm reduction research, particularly around syringe services programs, public health vending machines, fentanyl test strips, and PrEP access among people who inject drugs. His studies frequently employ mixed methods, combining quantitative modeling with qualitative insights, and focus on underserved rural communities in Appalachia and the Midwest. Geospatial analysis is a key methodological strength in assessing healthcare access disparities. Dr. Allen has no listed scientific awards in the provided text. He has advised or collaborated with numerous researchers and institutions, though specific student names are not listed. His work is supported by active research projects, including adapting HIV prevention interventions for rural populations and implementing syringe services in Indigenous communities. He has been involved in national policy discussions, including during his tenure at the White House ONDCP. Dr. Allen leads or contributes to innovative projects such as public health vending machines and network-oriented HIV prevention, particularly in rural and Indigenous settings. His research often involves community-based participatory approaches and policy evaluation.

Dan Smallمشاهده پروفایل

پژوهشگر

• Medical Anthropology
• Harm Reduction
• Public Health Policy
• +۷ مورد دیگر

Dan Small is an Honorary Research Associate in the Department of Anthropology at the University of British Columbia. He holds a PhD in medical anthropology from UBC, an MPhil in circumpolar studies from the University of Cambridge, and dual undergraduate degrees in sociology/anthropology and psychology from Simon Fraser University (both with first-class honours). His work focuses on harm reduction, healthcare culture, and marginalized populations, with a particular emphasis on supervised injection facilities and systemic barriers to healthcare access. Dr. Small has developed and evaluated initiatives such as social enterprises, housing programs, and healthcare services for vulnerable communities. His role in establishing Insite, North America’s only supervised injection facility, involved navigating complex socio-political challenges. He also contributed to medical regulation through roles with the College of Physicians and Surgeons of BC and the Medical Council of Canada. His research interests include medical ethics, peer-to-peer regulation, therapeutic narratives, and globalization’s impact on health. He has taught in anthropology and sociology, emphasizing critical approaches to healthcare and social justice. Scientific Awards and Achievements: Dr. Small has received prestigious awards including the UBC Canadian Airlines Travel Prize (1998), Queen Elizabeth II Centennial Scholarship (1996), and multiple SSHRC fellowships. His work bridges academic research and activism, advocating for evidence-based policies that prioritize marginalized communities. Advising and Grants: While specific grants are not detailed, his extensive involvement in program development and policy advocacy highlights his leadership in securing resources for harm reduction initiatives. He actively collaborates with interdisciplinary teams to advance healthcare equity. Labs/Teams: Central to his work is the interdisciplinary collaboration with the Insite team and community organizations in Vancouver’s Downtown Eastside. His research often integrates participatory methods, ensuring marginalized voices shape policy and practice.

Olivia Sugarmanمشاهده پروفایل

استادیار

• Health Policy
• Health Services Research
• Substance Use
• +۱۵ مورد دیگر

Olivia Sugarman, PhD, MPH, is an Assistant Scientist in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Her research centers on health policy and services for marginalized populations, particularly people who use drugs and those involved in the criminal-legal system. She utilizes mixed methods, health behavior frameworks, and community-partnered research to evaluate policies affecting access to mental health and substance use treatment, with a focus on equity and harm reduction. PhD in Behavioral and Community Health Sciences, LSU Health Sciences Center, 2022 MPH in Global Community Health and Behavioral Sciences, Tulane University, 2016 BS in Pre-Professional Sciences, University of Notre Dame, 2014 Postdoctoral Training, Bloomberg Overdose Prevention Initiative, Johns Hopkins, 2022–2024 Dr. Sugarman’s research interests include opioid use disorder, HIV/HCV, Medicaid policy, incarceration and health, and program evaluation. She investigates how policy reforms impact treatment access and outcomes, including studies on buprenorphine retention, naloxone distribution, and co-treatment of hepatitis C and addiction. Her work often involves analyzing large administrative datasets and qualitative community input. Her recent publications reveal a strong focus on emerging drug supply threats like xylazine, state-level policy responses, and overdose prevention strategies. She has published in leading journals such as Health Affairs , JAMA Health Forum , and Drug and Alcohol Dependence , highlighting trends in policy evaluation, health equity, and real-world implementation of evidence-based interventions. Scientific Awards: Teaching Excellent Recognition, Course 305.861.71: Graduate Seminar in Injury Research and Policy, Term 1, 2024 Dr. Sugarman has been involved in significant grant-funded projects, including the Bloomberg Overdose Prevention Initiative, where she leads evaluation efforts across seven states. She mentors students and collaborates widely with public health agencies and community organizations. She has advised on policy implementation and evaluation, particularly in Maryland and Louisiana. Her work bridges research, policy, and community engagement to improve health outcomes for vulnerable populations. She is actively involved in research teams focused on overdose prevention, mental health policy in correctional settings, and harm reduction service delivery. Her lab and collaborative networks include data scientists, epidemiologists, and policy analysts working on linked state databases and mixed-methods studies.

Caleb Banta-Greenمشاهده پروفایل

استاد پژوهشی

• Substance Abuse
• Addiction
• Opioid Use Disorder
• +۸ مورد دیگر

Caleb Banta-Green is a Research Professor at the University of Washington School of Public Health, Department of Health Services , and serves as Director of the Center for Community-Engaged Drug Education, Epidemiology & Research . He is affiliated with the Addictions, Drug & Alcohol Institute (ADAI) , Division of Addictions , and Harborview Injury Prevention & Research Center . Dr. Banta-Green's research focuses on substance use epidemiology , harm reduction , and health services for marginalized populations , particularly those affected by opioid and stimulant use . His work spans implementation science , policy evaluation , and community-based interventions , addressing accessibility for unhoused individuals, syringe service program users, and those in the criminal legal system. Recent publications highlight his contributions to opioid use disorder treatment (2025), fentanyl epidemic response (2025), medication access policy (2024), and methamphetamine user experiences (2023). His work integrates clinical trials , qualitative research , and secondary data analysis to improve treatment outcomes and reduce overdose risks. Technical contributions include co-developing public health resources at http://stopoverdose.org and http://learnabouttreatment.org , along with participation in U.S. Health and Human Services' Interdepartmental Substance Use Disorders Coordinating Committee .

Kristin Schneiderمشاهده پروفایل

استاد پژوهشی

• Overdose Prevention
• Harm Reduction
• Substance Use Epidemiology
• +۴ مورد دیگر

Kristin E. Schneider, PhD, is an Associate Research Professor in the Department of Health, Behavior and Society at Johns Hopkins University. Her work focuses on harm reduction strategies to address overdose and infectious disease risks among marginalized populations in both urban and rural settings. She holds a PhD from Johns Hopkins (2019) and a BA from New York University (2013). Dr. Schneider's research emphasizes translational implications for policy and practice, particularly around naloxone programs, syringe services, and overdose prevention initiatives. Education: PhD in Public Health, Johns Hopkins University, 2019 BA in Psychology, New York University, 2023 Research Interests: Dr. Schneider investigates overdose prevention, harm reduction practices, polysubstance use epidemiology, and social determinants of health. Her work bridges clinical and community-based approaches to address structural vulnerabilities faced by people who use drugs. Recent projects include evaluation of overdose data systems and studies on xylazine contamination in the drug supply. Key Scientific Contributions: Her 2023 work revealed increased solitary drug use during the pandemic, while 2021 research identified fentanyl's role in overdose fatalities. She has authored over 80 peer-reviewed articles, with a focus on rural health disparities and HIV risk behaviors among injection drug users. Awards: Recipient of the 2023 Baltimore Public Health Practice Excellence Award for innovative harm reduction strategies. Professional Activities: Leads the Overdose Data 2 Action initiative and the REFLEX study on xylazine's health impacts. Collaborates with syringe service programs and conducts community-engaged research to inform evidence-based policies.

Scott Burrisمشاهده پروفایل

استاد

• Public Health Law
• International Public Health Law
• Legal Epidemiology
• +۷ مورد دیگر

Scott Burris is a Professor of Law at Temple Law School and Professor in Temple's School of Public Health, where he directs the Center for Public Health Law Research. He has been a faculty member at Temple since 1991 and is internationally recognized for his pioneering work in public health law, particularly in legal epidemiology, policy surveillance, and the intersection of law with HIV/AIDS policy and substance abuse. Professor Burris received his J.D. from Yale Law School and his B.A. from Washington University in St. Louis. His career began during the early days of the HIV/AIDS epidemic, where he served as an attorney at the American Civil Liberties Union, lobbying and litigating on behalf of people with HIV. He edited the first systematic legal analysis of HIV in the United States, "AIDS and the Law: A Guide for the Public" (Yale University Press, 1987). Burris's research focuses on how law influences public health and health behavior, with particular emphasis on developing theory and methods for effective local health governance. His work spans international public health law, legal epidemiology, policy surveillance, substance abuse policy, and housing law. He has made significant contributions to understanding the impact of law on HIV prevention, opioid overdose prevention, and pandemic response. His recent work increasingly examines methodological rigor in legal epidemiology, the application of artificial intelligence to legal analysis, and the relationship between housing law and health equity. His extensive publication record includes over 200 books, book chapters, articles, and reports. Recent publications demonstrate his continued leadership in advancing the science of legal epidemiology, with particular attention to methodology, policy surveillance systems, and innovative applications of technology to legal analysis. American Public Health Association Law Section Lifetime Achievement Award (2014) Jay Healey Health Law Professors award (2018) Professor Burris has served as a consultant to numerous international organizations including the United Nations Development Programme, the World Health Organization, and the United Nations Office on Drugs and Crime. He founded the Public Health Law Research Program for the Robert Wood Johnson Foundation in 2009, which has supported over 80 empirical studies of the impact of law on health. His research has been funded by major organizations including the Robert Wood Johnson Foundation, the Open Society Institute, the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention. He is the founder of Legal Science, LLC, a private company dedicated to improving access to legal information and supporting policy surveillance practice. He also serves as an advisor to several international institutions including the Tsinghua University AIDS Institute, the Shanghai Academy of Social Sciences Research Center for HIV/AIDS Public Policy, and the Program in Bioethics at Monash University. His work bridges academic research, practical application, and policy development in the field of public health law.